Evidence map›Paper›PMID 32466452›Full record

ArticleGenes2020

NIPT Technique Based on the Use of Long Chimeric DNA Reads.

Vera Belova, Daria Plakhina, Sergey Evfratov, Kirill Tsukanov, Gennady Khvorykh, Alexander Rakitko, Alexander Konoplyannikov, Valery Ilinsky, Denis Rebrikov, Dmitriy Korostin

Open access · goldAbstract read
In one paragraph

Article in Genes, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Vera BelovaCenter for Precision Genome Editing and Genetic Technologies for Biomedicine, Pirogov Medical University, 1 Ostrovityanova street, 117997 Moscow, Russia.
Daria PlakhinaGenotek Ltd., 17-1-14 Nastavnicheskiy pereulok, 105120 Moscow, Russia.
Sergey EvfratovGenotek Ltd., 17-1-14 Nastavnicheskiy pereulok, 105120 Moscow, Russia.
Kirill TsukanovGenotek Ltd., 17-1-14 Nastavnicheskiy pereulok, 105120 Moscow, Russia.
Gennady KhvorykhGenotek Ltd., 17-1-14 Nastavnicheskiy pereulok, 105120 Moscow, Russia.
Alexander RakitkoGenotek Ltd., 17-1-14 Nastavnicheskiy pereulok, 105120 Moscow, Russia.
Alexander KonoplyannikovCenter for Precision Genome Editing and Genetic Technologies for Biomedicine, Pirogov Medical University, 1 Ostrovityanova street, 117997 Moscow, Russia.
Valery IlinskyGenotek Ltd., 17-1-14 Nastavnicheskiy pereulok, 105120 Moscow, Russia.
Denis RebrikovCenter for Precision Genome Editing and Genetic Technologies for Biomedicine, Pirogov Medical University, 1 Ostrovityanova street, 117997 Moscow, Russia.
Dmitriy KorostinCenter for Precision Genome Editing and Genetic Technologies for Biomedicine, Pirogov Medical University, 1 Ostrovityanova street, 117997 Moscow, Russia.
Pirogov Russian National Research Medical University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-invasive prenatal testing (NIPT) for aneuploidy on Chromosomes 21 (T21), 18 (T18) and 13 (T13) is actively used in clinical practice around the world. One of the limitations of the wider implementation of this test is the high cost of the analysis itself, as high-throughput sequencing is still relatively expensive. At the same time, there is an increasing trend in the length of reads yielded by sequencers. Since extracellular DNA is short, in the order of 140-160 bp, it is not possible to effectively use long reads. The authors used high-performance sequencing of cell-free DNA (cfDNA) libraries that went through additional stages of enzymatic fragmentation and random ligation of the resulting products to create long chimeric reads. The authors used a controlled set of samples to analyze a set of cfDNA samples from pregnant women with a high risk of fetus aneuploidy according to the results of the first trimester screening and confirmed by invasive karyotyping of the fetus using laboratory and analytical approaches developed by the authors. They evaluated the sensitivity, specificity, PPV (positive predictive value), and NPV (negative predictive value) of the results. The authors developed a technique for constructing long chimeric reads from short cfDNA fragments and validated the test using a control set of extracellular DNA samples obtained from pregnant women. The obtained sensitivity and specificity parameters of the NIPT developed by the authors corresponded to the approaches proposed earlier (99.93% and 99.14% for T21; 100% and 98.34% for T18; 100% and 99.17% for T13, respectively).

Indexed as

AneuploidyAdultCell-Free Nucleic AcidsChimeraChromosomes, Human, Pair 13Chromosomes, Human, Pair 18Chromosomes, Human, Pair 21FemaleHumansPregnancyPrenatal DiagnosisTrisomy 13 SyndromeTrisomy 18 SyndromeCell-Free Nucleic AcidscfDNAchimeric DNAfetal fractionlong chimeric readsNGSNIPTshort DNA fragments

Identifiers

PMID32466452
PMCPMC7349339
OpenAlexW3030351387

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.